Liver transplantation as definitive treatment for A factory V Leiden mutationDUNN, Stephen P; TSAI, Anthony; GRIFFIN, Gregory et al.The Journal of pediatrics. 2005, Vol 146, Num 3, pp 418-422, issn 0022-3476, 5 p.Article

Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P'₁ permutationsBURNS, David M; CHUNHONG HE; FRIDMAN, Jordan S et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 2, pp 560-564, issn 0960-894X, 5 p.Article

Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionBURNS, David M; LI, Yun-Long; COVINGTON, Maryanne B et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 13, pp 3525-3530, issn 0960-894X, 6 p.Article

Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWENQING YAO; JINCONG ZHUO; MARANDO, Cindy A et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 1, pp 159-163, issn 0960-894X, 5 p.Article

Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancerWENQING YAO; JINCONG ZHUO; QIYAN LIN et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 4, pp 603-606, issn 0022-2623, 4 p.Article